Merck Kgaa's Acquisition of Bio-techne Makes Strategic Sense

Dow Jones

06/26

1622 GMT - Merck KGaA's deal to buy Bio-Techne makes sense from a strategic rationale perspective, with the German company upgrading its life-science portfolio, Bernstein says in a research note. Bernstein says the valuation on the U.S. life-sciences tools supplier looks expensive but notes that the market appears to like the deal, with Merck's shares gaining after the news. The price tag also raises the question of whether the sector sees life sciences tools as a winner in the AI space, according to Bernstein. "We expect this deal to go through with no hitches," Bernstein says. Merck shares closed 4.9% higher at 147 euros. (sarah.sloat@wsj.com)

(END) Dow Jones Newswires

June 25, 2026 12:22 ET (16:22 GMT)

应版权方要求，你需要登录查看该内容

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hans/news/2646102802"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2646102802\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2646102802?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-26 00:22","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2646102802","market":"other","top_or_hot":-1,"title":"Merck Kgaa's Acquisition of Bio-techne Makes Strategic Sense","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n     1622 GMT - <a href=\"https://laohu8.com/S/MKGAF\">Merck KGaA</a>'s deal to buy Bio-Techne makes sense from a strategic rationale perspective, with the German company upgrading its life-science portfolio, Bernstein says in a research note. Bernstein says the valuation on the U.S. life-sciences tools supplier looks expensive but notes that the market appears to like the deal, with Merck's shares gaining after the news. The price tag also raises the question of whether the sector sees life sciences tools as a winner in the AI space, according to Bernstein. \"We expect this deal to go through with no hitches,\" Bernstein says. Merck shares closed 4.9% higher at 147 euros. (sarah.sloat@wsj.com) \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  June 25, 2026 12:22 ET (16:22 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Merck Kgaa's Acquisition of Bio-techne Makes Strategic Sense</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMerck Kgaa's Acquisition of Bio-techne Makes Strategic Sense\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2026-06-26 00:22</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n     1622 GMT - <a href=\"https://laohu8.com/S/MKGAF\">Merck KGaA</a>'s deal to buy Bio-Techne makes sense from a strategic rationale perspective, with the German company upgrading its life-science portfolio, Bernstein says in a research note. Bernstein says the valuation on the U.S. life-sciences tools supplier looks expensive but notes that the market appears to like the deal, with Merck's shares gaining after the news. The price tag also raises the question of whether the sector sees life sciences tools as a winner in the AI space, according to Bernstein. \"We expect this deal to go through with no hitches,\" Bernstein says. Merck shares closed 4.9% higher at 147 euros. (sarah.sloat@wsj.com) \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  June 25, 2026 12:22 ET (16:22 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"IE0034390439.USD","symbol_name":"FTGF ROYCE US SMALLER COMPANIES \"A\" (USD) D","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2646102802","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2646102802","pubTimestamp":1782404520,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"1622 GMT - Merck KGaA's deal to buy Bio-Techne makes sense from a strategic rationale perspective, with the German company upgrading its life-science portfolio, Bernstein says in a research note. Bernstein says the valuation on the U.S. life-sciences tools supplier looks expensive but notes that the market appears to like the deal, with Merck's shares gaining after the news. The price tag also raises the question of whether the sector sees life sciences tools as a winner in the AI space, according to Bernstein. \"We expect this deal to go through with no hitches,\" Bernstein says. Merck shares closed 4.9% higher at 147 euros.  Dow Jones NewswiresJune 25, 2026 12:22 ET Copyright  2026 Dow Jones & Company, Inc.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"IE0034390439.USD":"FTGF ROYCE US SMALLER COMPANIES \"A\" (USD) D","TECH":"Bio-Techne","BK4007":"制药","IE00B64QTZ34.USD":"NEUBERGER BERMAN US SMALL CAP \"A\" (USD) ACC","BK4121":"生命科学工具和服务","BK4588":"碎股","IE00B19Z6F94.USD":"Legg Mason Royce - US Smaller Companies A Acc USD","BK4585":"ETF&股票定投概念","LU2237957811.SGD":"NIKKO AM GLOBAL EQUITY \"F\" (SGD) ACC","MKKGY":"Merck KGaA","LU2237957902.USD":"NIKKO AM GLOBAL EQUITY \"F\" (USD) ACC"},"translate_title":"Merck Kgaa收购Bio-techne具有战略意义","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"MKKGY":1.94,"TECH":1.9},"content_text":"1622 GMT - Merck KGaA's deal to buy Bio-Techne makes sense from a strategic rationale perspective, with the German company upgrading its life-science portfolio, Bernstein says in a research note. Bernstein says the valuation on the U.S. life-sciences tools supplier looks expensive but notes that the market appears to like the deal, with Merck's shares gaining after the news. The price tag also raises the question of whether the sector sees life sciences tools as a winner in the AI space, according to Bernstein. \"We expect this deal to go through with no hitches,\" Bernstein says. Merck shares closed 4.9% higher at 147 euros. (sarah.sloat@wsj.com) \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  June 25, 2026 12:22 ET (16:22 GMT)\n\n\n  Copyright (c) 2026 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":true,"need_login_tip":false,"code":"91000000","status":"200"}}}